AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 31923632 — intervention group
Group type: EXPERIMENTAL
Intervention: Photodynamic therapy with methylene blue and 660 nm diode laser (25 mW, dose: 19.23 J/CM2, probe diameter: 0.78 cm2) for three sessions (day 1, 3, 5)
Number of subjects: 15
Study 31923632 — intervention group
Group type: COMPARATOR
Intervention: Sham laser treatment on control side
Number of subjects: 15
Study 31537217 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive insulin therapy (IIT), keeping blood glucose at 4.4-7.8 mmol/L
Number of subjects: 52
Study 31537217 — intervention group
Group type: COMPARATOR
Intervention: Conventional glycemic therapy (CGT), keeping blood glucose at 7.8-12.2 mmol/L
Number of subjects: 52
Study 26905864 — intervention group
Group type: EXPERIMENTAL
Intervention: HD203
Number of subjects: 294
Study 26905864 — intervention group
Group type: COMPARATOR
Intervention: ETN
Number of subjects: 294
Study 26307899 — intervention group
Group type: EXPERIMENTAL
Intervention: Basal Bolus insulin regimen (glargine once daily and glulisine before meals)
Number of subjects: 279
Study 26307899 — intervention group
Group type: COMPARATOR
Intervention: Basal Plus insulin regimen (glargine once daily plus correction doses of glulisine before meals for glucose >140 mg/dL)
Number of subjects: 279
Study 26307899 — intervention group
Group type: EXPERIMENTAL
Intervention: Basal Bolus insulin regimen
Number of subjects: 279
Study 26307899 — intervention group
Group type: COMPARATOR
Intervention: Basal Plus insulin regimen
Number of subjects: 279
Study 26307899 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with hypoglycemia events
Number of subjects: 279
Study 26307899 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycemic variability (GV)
Number of subjects: 279
Study 24199923 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopy
Number of subjects: 198
Study 24199923 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopy combined with Leuprolide acetate (3.75 mg every 28 days)
Number of subjects: 198
Study 24199923 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopy combined with Goserelin acetate (3.6 mg every 28 days)
Number of subjects: 198
Study 16434174 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled fluticasone propionate (FP) 1000 microg daily
Number of subjects: 93
Study 16434174 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled fluticasone propionate (FP) 500 microg bid
Number of subjects: 93
Study 16434174 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 93
Study 14598619 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine 2% + adrenaline 1/80,000
Number of subjects: 40
Study 14598619 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 10670165 — intervention group
Group type: EXPERIMENTAL
Intervention: Healon (1% sodium hyaluronate)
Number of subjects: 20
Study 10670165 — intervention group
Group type: COMPARATOR
Intervention: Viscoat (4% chondroitin sulfate and 3% sodium hyaluronate)
Number of subjects: 20
Study 8933545 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefuroxime axetil (30 mg/kg/day)
Number of subjects: 78
Study 8933545 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefaclor (40 mg/kg/day)
Number of subjects: 78
Study 1725544 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril alone
Number of subjects: 0
Study 1725544 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril in combination with diltiazem
Number of subjects: 0
Study 1725544 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril in combination with nifedipine
Number of subjects: 0
Study 1725544 — intervention group
Group type: COMPARATOR
Intervention: Diltiazem
Number of subjects: 0
Study 1725544 — intervention group
Group type: COMPARATOR
Intervention: Nifedipine
Number of subjects: 0
Study 6412586 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentazocine
Number of subjects: 30
Study 6412586 — intervention group
Group type: EXPERIMENTAL
Intervention: Piritramid
Number of subjects: 30
Study 6412586 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine
Number of subjects: 30
Study 31341523 — intervention group
Group type: EXPERIMENTAL
Intervention: Core stability training monitored by rehabilitative ultrasound imaging and surface electromyogram
Number of subjects: 60
Study 31341523 — intervention group
Group type: COMPARATOR
Intervention: Identical training without monitoring (Control)
Number of subjects: 60
Study 27810294 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle intervention
Number of subjects: 12245
Study 25137367 — intervention group
Group type: COMPARATOR
Intervention: Sitting (SIT) trial
Number of subjects: 12
Study 25137367 — intervention group
Group type: EXPERIMENTAL
Intervention: Breaking ST (ACT) trial
Number of subjects: 12
Study 23537462 — intervention group
Group type: EXPERIMENTAL
Intervention: H-Wave(®) Device stimulation plus usual care
Number of subjects: 114
Study 23537462 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation (TENS) plus usual care
Number of subjects: 114
Study 23537462 — intervention group
Group type: COMPARATOR
Intervention: Sham electrotherapy plus usual care
Number of subjects: 114
Study 21755829 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E supplementation (600 mg/daily for three months)
Number of subjects: 40
Study 21755829 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 40
Study 21755829 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E supplementation
Number of subjects: 40
Study 19171070 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention for problem focused therapy (2 x 2 hours)
Number of subjects: 0
Study 19171070 — intervention group
Group type: COMPARATOR
Intervention: Usual care (general advice on sleep hygiene and pharmacotherapy with hypnotic drugs)
Number of subjects: 0
Study 16721457 — intervention group
Group type: EXPERIMENTAL
Intervention: NSK reciprocating handpiece (TEP-E10R, Nakanishi Inc.) powered by an electric motor (Endo Plus; VK Driller) used by a general dentist
Number of subjects: 84
Study 16721457 — intervention group
Group type: EXPERIMENTAL
Intervention: NSK reciprocating handpiece (TEP-E10R, Nakanishi Inc.) powered by an electric motor (Endo Plus; VK Driller) used by an endodontist
Number of subjects: 84
Study 16721457 — intervention group
Group type: EXPERIMENTAL
Intervention: NSK reciprocating handpiece (TEP-E10R, Nakanishi Inc.) powered by an electric motor (Endo Plus; VK Driller) used by a third-year dental student
Number of subjects: 84
Study 16721457 — intervention group
Group type: COMPARATOR
Intervention: NSK reciprocating handpiece (TEP-E10R, Nakanishi Inc.) powered by an electric motor (Endo Plus; VK Driller) used by a professor of Endodontics
Number of subjects: 84
Study 14712421 — intervention group
Group type: EXPERIMENTAL
Intervention: N-Acetylcysteine (NAC)
Number of subjects: 885
Study 14712421 — intervention group
Group type: COMPARATOR
Intervention: Control group (no NAC)
Number of subjects: 885
Study 11524315 — intervention group
Group type: EXPERIMENTAL
Intervention: Pheresis
Number of subjects: 90
Study 11524315 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 90
Study 9215819 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel 200 mg/m2 and Epirubicin 90 mg/m2
Number of subjects: 50
Study 9215819 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel 225 mg/m2
Number of subjects: 50
Study 9215819 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel 175 to 225 mg/m2
Number of subjects: 50
Study 9215819 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel 175 mg/m2 and 225 mg/m2
Number of subjects: 50
Study 9215819 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel and Epirubicin combination
Number of subjects: 50
Study 7584263 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific warning presented immediately after misleading information
Number of subjects: 0
Study 7584263 — intervention group
Group type: COMPARATOR
Intervention: Misleading post-event information
Number of subjects: 0
Study 3312050 — intervention group
Group type: EXPERIMENTAL
Intervention: Vertical banded gastroplasty (GP)
Number of subjects: 74
Study 3312050 — intervention group
Group type: COMPARATOR
Intervention: Horizontal gastroplasty (GP)
Number of subjects: 74
Study 29244197 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate Treatment (IT)
Number of subjects: 130
Study 29244197 — intervention group
Group type: COMPARATOR
Intervention: Delayed Treatment (DT)
Number of subjects: 130
Study 27240430 — intervention group
Group type: EXPERIMENTAL
Intervention: FAST+SAM
Number of subjects: 37
Study 27240430 — intervention group
Group type: COMPARATOR
Intervention: FAST
Number of subjects: 37
Study 25678057 — intervention group
Group type: EXPERIMENTAL
Intervention: Multipoint left ventricular pacing (MPP)
Number of subjects: 44
Study 25678057 — intervention group
Group type: COMPARATOR
Intervention: Conventional cardiac resynchronization therapy (CONV)
Number of subjects: 44
Study 23997147 — intervention group
Group type: EXPERIMENTAL
Intervention: Synthetic cast
Number of subjects: 199
Study 23997147 — intervention group
Group type: COMPARATOR
Intervention: Plaster of Paris cast (POP)
Number of subjects: 199
Study 21902686 — intervention group
Group type: EXPERIMENTAL
Intervention: Mitoxantrone/cytarabine/etoposide
Number of subjects: 504
Study 21902686 — intervention group
Group type: COMPARATOR
Intervention: Daunorubicin/cytarabine/etoposide
Number of subjects: 504
Study 21902686 — intervention group
Group type: COMPARATOR
Intervention: Four courses of treatment
Number of subjects: 504
Study 18349405 — intervention group
Group type: EXPERIMENTAL
Intervention: Mitoxantrone (12 mg/m(2))
Number of subjects: 983
Study 18349405 — intervention group
Group type: COMPARATOR
Intervention: Androgen-deprivation therapy (ADT)
Number of subjects: 983
Study 17024571 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryoablation using a 9 French 8 mm tip Freezor Max catheter
Number of subjects: 32
Study 17024571 — intervention group
Group type: COMPARATOR
Intervention: Radiofrequency ablation using an 8 mm tip Blazer II XP catheter
Number of subjects: 32
Study 12649819 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual art group (using Edvard Munch's painting, 'The Sick Girl')
Number of subjects: 144
Study 12649819 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 144
Study 10914803 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronally positioned flap procedure with bioabsorbable membrane
Number of subjects: 20
Study 10914803 — intervention group
Group type: COMPARATOR
Intervention: Coronally positioned flap procedure without bioabsorbable membrane
Number of subjects: 20
Study 8726152 — intervention group
Group type: EXPERIMENTAL
Intervention: Sedated with chloral hydrate, inhaled aerosol of 7.7 microns mass median diameter (MMD)
Number of subjects: 20
Study 8726152 — intervention group
Group type: EXPERIMENTAL
Intervention: Not sedated, inhaled aerosol of 7.7 microns mass median diameter (MMD)
Number of subjects: 20
Study 8726152 — intervention group
Group type: COMPARATOR
Intervention: Not sedated, inhaled aerosol with an MMD of 3.6 microns
Number of subjects: 20
Study 1444308 — intervention group
Group type: EXPERIMENTAL
Intervention: Aluminum hydroxide (1 g) with DR-3355 (100 mg)
Number of subjects: 3
Study 1444308 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium oxide (500 mg) with DR-3355 (100 mg)
Number of subjects: 3
Study 1444308 — intervention group
Group type: EXPERIMENTAL
Intervention: Ferrous sulfate (160 mg) with DR-3355 (100 mg)
Number of subjects: 3
Study 1444308 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium carbonate (1 g) with DR-3355 (100 mg)
Number of subjects: 3
Study 1444308 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine (150 mg) with DR-3355 (100 mg)
Number of subjects: 3
Study 1444308 — intervention group
Group type: COMPARATOR
Intervention: DR-3355 (100 mg) alone
Number of subjects: 3
Study 6366771 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefaclor
Number of subjects: 100
Study 6366771 — intervention group
Group type: COMPARATOR
Intervention: Trimethoprim-sulfamethoxazole (TMP-SMX)
Number of subjects: 100
Study 6366771 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefaclor (additional course)
Number of subjects: 100
Study 31655296 — intervention group
Group type: EXPERIMENTAL
Intervention: Alisertib plus Paclitaxel
Number of subjects: 178
Study 31655296 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus Paclitaxel
Number of subjects: 178
Study 28823721 — intervention group
Group type: EXPERIMENTAL
Intervention: ω‐3 polyunsaturated fatty acids (PUFA)
Number of subjects: 81
Study 28823721 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 81
Study 25373430 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide nebulization (0.5 mg in 2.5 ml normal saline, given within 2 hours of birth and a second dose at 12 hours)
Number of subjects: 78
Study 25373430 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide nebulization
Number of subjects: 78
Study 25373430 — intervention group
Group type: COMPARATOR
Intervention: Normal saline nebulization (control)
Number of subjects: 78
Study 24576321 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (200 mW) at 2 J
Number of subjects: 28
Study 24576321 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (200 mW) at 6 J
Number of subjects: 28
Study 24576321 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (200 mW) at 10 J
Number of subjects: 28
Study 24576321 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0 J)
Number of subjects: 28
Study 24576321 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (100 mW) - best dose from phase 1
Number of subjects: 28
Study 24576321 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (200 mW) - best dose from phase 1
Number of subjects: 28
Study 24576321 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (400 mW) - best dose from phase 1
Number of subjects: 28
Study 24576321 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0 mW)
Number of subjects: 28
Study 22181685 — intervention group
Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (PDT)
Number of subjects: 32
Study 22181685 — intervention group
Group type: EXPERIMENTAL
Intervention: Diode soft laser (DSL)
Number of subjects: 32
Study 22181685 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional deep scaling and root planing (SRP)
Number of subjects: 32
Study 22181685 — intervention group
Group type: COMPARATOR
Intervention: All treatments (PDT, DSL, SRP)
Number of subjects: 32
Study 19907002 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoproterenol (ISO): 12 ng.kg fat free mass(‐1).min(‐1)
Number of subjects: 10
Study 19907002 — intervention group
Group type: COMPARATOR
Intervention: Saline (CON)
Number of subjects: 10
Study 17655657 — intervention group
Group type: EXPERIMENTAL
Intervention: Finasteride 5 mg with counseling on sexual side effects (group 2)
Number of subjects: 120
Study 17655657 — intervention group
Group type: COMPARATOR
Intervention: Finasteride 5 mg without counseling on sexual side effects (group 1)
Number of subjects: 120
Study 16301384 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical 0.05% tretinoin solution (Retin‐A)
Number of subjects: 24
Study 16301384 — intervention group
Group type: COMPARATOR
Intervention: Placebo saline solution
Number of subjects: 24
Study 11888099 — intervention group
Group type: EXPERIMENTAL
Intervention: Early amniotomy
Number of subjects: 168
Study 11888099 — intervention group
Group type: COMPARATOR
Intervention: Late amniotomy
Number of subjects: 168
Study 10051060 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium valproate (VPA) 1000 mg
Number of subjects: 16
Study 10051060 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium valproate (VPA) 2000 mg
Number of subjects: 16
Study 10051060 — intervention group
Group type: EXPERIMENTAL
Intervention: EEG power spectrum
Number of subjects: 16
Study 10051060 — intervention group
Group type: EXPERIMENTAL
Intervention: Other neurophysiologic tests
Number of subjects: 16
Study 8583019 — intervention group
Group type: EXPERIMENTAL
Intervention: Augmentin
Number of subjects: 98
Study 8583019 — intervention group
Group type: EXPERIMENTAL
Intervention: Tetracycline
Number of subjects: 98
Study 8583019 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen
Number of subjects: 98
Study 8583019 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 98
Study 2126144 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvoxamine
Number of subjects: 90
Study 2126144 — intervention group
Group type: EXPERIMENTAL
Intervention: Desipramine
Number of subjects: 90
Study 2126144 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study 430581 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycerol test with positive instruction (hearing would improve)
Number of subjects: 0
Study 430581 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycerol test with negative instruction (hearing would worsen)
Number of subjects: 0
Study 430581 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 0
Study 28027911 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 (2800 IU per day for 8 weeks)
Number of subjects: 200
Study 28027911 — intervention group
Group type: COMPARATOR
Intervention: Placebo (for 8 weeks)
Number of subjects: 200
Study 28027911 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 (in subgroup with 25(OH)D <20ng/mL)
Number of subjects: 200
Study 26678866 — intervention group
Group type: EXPERIMENTAL
Intervention: Training of professionals in adherence to suicide guidelines (e-learning supported train-the-trainer programme)
Number of subjects: 566
Study 25692980 — intervention group
Group type: EXPERIMENTAL
Intervention: Yacon-based product (YBP) with 10 g fructooligosaccharide (FOS)/inulin per day in orange juice
Number of subjects: 48
Study 25692980 — intervention group
Group type: COMPARATOR
Intervention: Maltodextrin in orange juice (control) with 25 g per day
Number of subjects: 48
Study 23065117 — intervention group
Group type: EXPERIMENTAL
Intervention: Melodic Based Communication Therapy (MBCT)
Number of subjects: 12
Study 23065117 — intervention group
Group type: COMPARATOR
Intervention: Traditional Speech and Language Therapy
Number of subjects: 12
Study 20578661 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% Povidone Iodine
Number of subjects: 30
Study 20578661 — intervention group
Group type: COMPARATOR
Intervention: Placebo (deionized water)
Number of subjects: 30
Study 18949672 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture during chemotherapy courses
Number of subjects: 23
Study 18949672 — intervention group
Group type: COMPARATOR
Intervention: Control courses (without acupuncture)
Number of subjects: 23
Study 17236400 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopically assisted vaginal hysterectomy (LAVH)
Number of subjects: 85
Study 17236400 — intervention group
Group type: COMPARATOR
Intervention: Total laparoscopic hysterectomy (TLH)
Number of subjects: 85
Study 11246259 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 Fr catheter with power injection
Number of subjects: 101
Study 11246259 — intervention group
Group type: COMPARATOR
Intervention: 6 Fr manual technique
Number of subjects: 101
Study 9540243 — intervention group
Group type: EXPERIMENTAL
Intervention: School-based program
Number of subjects: 24
Study 9540243 — intervention group
Group type: COMPARATOR
Intervention: Treatment-based program
Number of subjects: 24
Study 7986972 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine 30 mg daily for two days
Number of subjects: 12
Study 7986972 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 2688592 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiaprofenic acid (Surgam)
Number of subjects: 106
Study 2688592 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 106
Study 8289408 — intervention group
Group type: EXPERIMENTAL
Intervention: Button (C.R. Bard, Inc)
Number of subjects: 42
Study 8289408 — intervention group
Group type: COMPARATOR
Intervention: Standard No. 14 French red rubber catheter
Number of subjects: 42
Study 517468 — intervention group
Group type: EXPERIMENTAL
Intervention: Anxiety management training
Number of subjects: 40
Study 517468 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive modification procedure
Number of subjects: 40
Study 517468 — intervention group
Group type: COMPARATOR
Intervention: No-treatment control group
Number of subjects: 40
Study 31262847 — intervention group
Group type: EXPERIMENTAL
Intervention: mHealth (self‐monitoring by free text/short message service [SMS])
Number of subjects: 40
Study 31262847 — intervention group
Group type: COMPARATOR
Intervention: Self‐monitoring without mHealth (self‐monitoring using paper diaries)
Number of subjects: 40
Study 29334435 — intervention group
Group type: EXPERIMENTAL
Intervention: Stannous fluoride dentifrice (Crest® Pro‐Health™ smooth formula)
Number of subjects: 120
Study 29334435 — intervention group
Group type: COMPARATOR
Intervention: Triclosan-containing dentifrice (Colgate® Total®)
Number of subjects: 120
Study 25582279 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral salmon calcitonin (sCT) 0.8 mg twice daily
Number of subjects: 2206
Study 25582279 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 2206
Study 23701835 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-year family-based healthy lifestyle intervention
Number of subjects: 203
Study 23701835 — intervention group
Group type: COMPARATOR
Intervention: Control group (paired-matched control communities)
Number of subjects: 203
Study 20886654 — intervention group
Group type: EXPERIMENTAL
Intervention: Maitland Grade III anterior‐to‐posterior joint mobilization treatment
Number of subjects: 20
Study 20886654 — intervention group
Group type: COMPARATOR
Intervention: Control treatment of rest for 5 min
Number of subjects: 20
Study 19034470 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic prophylaxis before skin incision (Group A)
Number of subjects: 389
Study 19034470 — intervention group
Group type: COMPARATOR
Intervention: Antibiotic prophylaxis after umbilical cord clamping (Group B)
Number of subjects: 389
Study 17689261 — intervention group
Group type: EXPERIMENTAL
Intervention: Informed consent with HIPAA authorization
Number of subjects: 384
Study 17689261 — intervention group
Group type: COMPARATOR
Intervention: Informed consent alone (control group)
Number of subjects: 384
Study 15345735 — intervention group
Group type: EXPERIMENTAL
Intervention: Health Enhancement Program
Number of subjects: 201
Study 15345735 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 201